Scarica l'app Stockscreener
48.75
0.25%
-0.12
Dopo l'orario di chiusura:
48.50
-0.25
-0.51%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRSP Giù?
Forum
Previsione
Crispr Therapeutics Ag Borsa (CRSP) Ultime notizie
CRISPR Therapeutics shares drop after announcing convertible notes sale - MSN
Cathie Wood’s ARK Invest Buys $10M in CRISPR and PayPay on Thursday - MEXC
ARK Invest Allocates $10M to CRISPR Therapeutics and PayPay in Latest Trading Session - MEXC
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know - Yahoo Finance
Q2 EPS Estimate for CRISPR Therapeutics Lifted by Analyst - MarketBeat
Assessing CRISPR Therapeutics (CRSP) Valuation After Upsized US$550m Convertible Notes Offering - Sahm
Wall Street Analysts See CRISPR Therapeutics (CRSP) as a Buy: Should You Invest? - MSN
ARK Investment Acquires 113K Shares of Crispr Therapeutics (CRSP) - GuruFocus
Insider Selling: CRISPR Therapeutics (NASDAQ:CRSP) General Counsel Sells 2,800 Shares of Stock - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) CEO Samarth Kulkarni Sells 9,798 Shares - MarketBeat
CRISPR Therapeutics (CRSP) counsel sells 2,800 shares to cover RSU taxes - Stock Titan
CRISPR Therapeutics (CRSP) CEO RSU vesting and 9,798-share tax sale - Stock Titan
CRISPR Therapeutics plans $350M convertible notes offering By Investing.com - Investing.com Nigeria
Research Analysts Set Expectations for CRSP FY2028 Earnings - MarketBeat
CRISPR Therapeutics prices $550M convertible notes offering By Investing.com - Investing.com Canada
CRISPR Therapeutics AG (CRSP) Falls Sharper Than Overall Market: Key Information to Note - Bitget
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know - Yahoo Finance
CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth - Insider Monkey
CRISPR Therapeutics Announces $350 Million Convertible Senior Notes Offering to Fund Gene-Editing Innovation - Minichart
CRISPR Therapeutics (CRSP) Sees Significant ARK Invest Purchase - GuruFocus
CRISPR Therapeutics (NASDAQ:CRSP) Sees Strong Trading VolumeHere's What Happened - MarketBeat
CRISPR Therapeutics prices $550 million convertible senior notes offering - The Pharma Letter
CRISPR Therapeutics (CRSP) Stock Plunges 10% as Cathie Wood’s ARK Invest Scoops Up Shares - MEXC
CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10% - AlphaStreet
CRISPR Therapeutics (CRSP) Stock Drops 10% — Cathie Wood’s Ark Buys the Dip - MEXC
CRISPR Therapeutics (CRSP) Upsizes Convertible Note Offering to $550M - GuruFocus
CRISPR Therapeutics (CRSP) Announces $550M Convertible Notes Offering - GuruFocus
CRISPR Therapeutics prices upsized convertible senior notes offering - marketscreener.com
Crispr Therapeutics Upsizes Convertible Notes Offering to $550 Million - TipRanks
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering - The Manila Times
CRISPR Therapeutics prices $550M upsized convertible notes due 2031 - TradingView
CRISPR Therapeutics AG Prices $550 Million Convertible Senior Notes Offering Due 2031 - Quiver Quantitative
CRISPR Therapeutics (NASDAQ: CRSP) prices $550M 2031 convertible notes - Stock Titan
CRISPR Therapeutics prices $550M convertible notes offering - Investing.com
Investors back CRISPR $550M notes, 45% premium conversion price - Stock Titan
CRISPR Therapeutics (CRSP) Stock Plunges 10% as Cathie Wood's ARK Invest Scoops Up Shares - Blockonomi
Cathie Wood buys the dip in gene-editing firm CRISPR Therapeutics (CRSP:NASDAQ) - Seeking Alpha
Capital International Investors Acquires 55,511 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics (CRSP) Announces $350M Convertible Notes Off - GuruFocus
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday - The Motley Fool
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday - The Motley Fool
Why is CRSP stock falling pre-market today? - MSN
CRSP Stock Declines Over 9% as Market Faces Downturn - GuruFocus
What's Going On With CRISPR Therapeutics Stock Today? - Benzinga
CRISPR Therapeutics (NASDAQ:CRSP) Shares Gap DownWhat's Next? - MarketBeat
CRISPR Therapeutics plans $350M convertible notes offering - Investing.com Australia
Crispr Therapeutics Falls on $350 Million Senior Note Private Placement - marketscreener.com
Here is Why CRISPR Therapeutics (CRSP) Appears so Good - Bitget
CRISPR Therapeutics stock dips on $350M convertible debt offering - MSN
Crispr Therapeutics Plans $350 Million Convertible Senior Notes Offering - marketscreener.com
Crispr Therapeutics announces proposed convertible senior notes offering - TipRanks
CRISPR Therapeutics stock falls on convertible notes offering By Investing.com - Investing.com India
Why Crispr Therapeutics Stock Is Sliding Today - TipRanks
CRISPR Therapeutics stock falls on convertible notes offering - Investing.com Nigeria
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering - The Manila Times
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):